Skip to main content
. 2021 Mar 1;12:649441. doi: 10.3389/fimmu.2021.649441

Figure 2.

Figure 2

Cytokine profile during treatment with daratumumab. Interleukin (IL)-6, IL-10, IL-17, interferon (IFN)-γ, tumor necrosis factor (TNF)-α, transforming growth factor (TGF)-β. Dashed line indicates the median values of 40 healthy controls.